PROBENECID IN MEN WITH ASTHENOZOOSPERMIA
Not Applicable
- Conditions
- Health Condition 1: N468- Other male infertility
- Registration Number
- CTRI/2023/05/052827
- Lead Sponsor
- Dr Tejas Gundewar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Infertile men with idiopathic asthenozoospermia on semen analysis.
2. Couples where female factor infertility has been ruled out.
Exclusion Criteria
Azoospermia.
2. Not willing to participate.
3. Varicocele.
4. Couples with female factor infertility
5. Diabetes
6. Epididymitis, orchitis and leucocytospermia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the effect of probenecid on rapid progressive sperm motility in infertile men with <br/ ><br>asthenospermia.Timepoint: Baseline and 12 weeks
- Secondary Outcome Measures
Name Time Method To study the effect of probenecid on slow progressive motility. <br/ ><br>2. To study the effect of probenecid on sperm count. <br/ ><br>3. To study the effect of probenecid on sperm morphology. <br/ ><br>4. To study the pregnancy rates after treatment with probenecid.Timepoint: Baseline and 12 weeks